The University of Chicago is launching a new one-year Master of Science (MS) in Biomedical Sciences program in Autumn Quarter 2023. Applications will open in September 2022 through March 15, 2023, ...

Biomedical sciences examine the intricate connections between genetics, physiology and the environment, uncovering how they shape health and disease. This dynamic field spans fundamental discovery to ...

The Biomedical Informatics and Data Science Training Program supports predoctoral and postdoctoral fellows. There are three general areas of emphasis in the training program: Clinical informatics - ...

Advance your career with Purdue University’s online Master of Science in Biomedical Engineering. Designed for professionals, this flexible program explores medical device design, tissue engineering, ...

Our natural sciences interdisciplinary master’s program is distinct from other biomedical master’s programs in the Jacobs School. While those programs are geared toward students looking for a focused ...

The PhD Program in Biomedical Sciences (PPBS) is the entry portal for ten PhD programs in the biomedical sciences: biochemistry; biomedical informatics; computational cell biology, anatomy and ...

Enrolling in the Baylor College of Medicine Graduate School of Biomedical Sciences opens doors to educational opportunities both within the College and with other outstanding institutions. The MS in ...

The term biomedical refers to a combination of biology and medicine to maintain and improve animal and human health. Some biomedical scientists are also physicians. A biomedical engineer works in the ...

The Biomedical Sciences Training Program is an interdisciplinary PhD umbrella program designed for student success. Every student is given the chance to explore our eleven different biomedical science ...

From neuroscience, to cancer biology, and regenerative medicine, exploration by biomedical scientists at City University of Hong Kong is searching for therapies for major global diseases. A premium ...

Proposed OMB grant review changes could shift science funding from peer-reviewed to subject to political whims, impacting drug development and patient care.